Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Sirtuin activators

Alcaín, Francisco J, Villalba, José M · 2009 · Expert Opinion on Therapeutic Patents

Abstract

BACKGROUND: Sirtuin 1-7 (SIRT1-7) are deacetylases that are dependent on NAD(+) for their activity. SIRT1 down-regulates p53 activity, increasing lifespan, cell survival, and neuroprotection; it also deacetylates peroxisome proliferator-activated receptor-gamma and its coactivator 1alpha, promoting fat mobilization, increasing mitochondrial size and number, and positively regulating insulin secretion. Sirtuins link nutrient availability and energy metabolism. Calorie restriction, which increases lifespan and is beneficial in age-related disorders, activates sirtuin. Major efforts are thus focused to developing sirtuin activators. OBJECTIVE: After discussing the potential involvement of sirtuins in pathophysiological processes, this review looks at new, synthetic sirtuin activators. CONCLUSIONS: To date, resveratrol is the most potent natural compound able to activate SIRT1, mimicking the positive effect of calorie restriction. Resveratrol might help in the treatment or prevention of obesity and in preventing the aging-related decline in heart function and neuronal loss. As resveratrol has low bioavailability and interacts with multiple molecular targets, the development of new molecules with better bioavailability and targeting sirtuin at lower concentrations is a promising field of the medicinal chemistry. New SIRT1 activators that are up to 1000 times more effective than resveratrol have recently been identified. These improve the response to insulin and increase the number and activity of mitochondria in obese mice. Human trials with a formulation of resveratrol with improved bioavailability and with a synthetic SIRT1 activator are in progress.

Overview

Integrity signals

Registry

Crossref · 10.1517/13543770902762893

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 71 references

Research works printed but not linked: 7

  1. Voelter-Mahlknecht, 2006, Int J Oncol, 28, 447
  2. Alcain, 2009, Expert Opin Ther Pat
  3. Lavu, 2008, Nature Rev, 7, 841
  4. Das, 2007, Drug Discov, 2, 133
  5. Pirola, 2008, Life, 60, 323
  6. Elliot, 2008, Curr Opin Inves Drugs, 9, 371
  7. Gescher, 2003, Cancer Epidemiol Biomarkers Preven, 12, 953

Cited by

See all 149

Metadata

Authors
Alcaín, F. J., & Villalba, J. M.
Affiliations
University of Córdoba (ES)
Venue
Expert Opinion on Therapeutic Patents
Published
2009-04
Volume
19
Issue
4
Pages
403-414
ISSN
  • 1354-3776 (ISSN-L)
  • 1744-7674
OpenAlex
W4230137195
Cited by
137
References
71
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 10 · 2021: 9 · 2020: 7 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 11 · 2014: 6 · 2013: 16 · 2012: 13
FWCI
9.96
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Therapeutic Patents (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
sirtuins, SIRT1 activators, resveratrol, caloric restriction mimetics, NAD+-dependent deacetylase, obesity, insulin sensitivity, mitochondrial biogenesis, p53, PPARγ, bioavailability, age-related decline, neuroprotection, cardiac function
MeSH terms
Resveratrol, Animals, Biological Availability, Flavonoids, Humans, Obesity, Phenols, Stilbenes, Drug Design, Drug Delivery Systems, Enzyme Activators, Sirtuins, Sirtuin 1, Polyphenols

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sirtuin activators. https://app.cochat.ai/papers/10.1517/13543770902762893
The paper
Alcaín, F. J., & Villalba, J. M. (2009). Sirtuin activators. Expert Opinion on Therapeutic Patents. https://doi.org/10.1517/13543770902762893

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.